» Articles » PMID: 16608061

MDCT-based 3-D Texture Classification of Emphysema and Early Smoking Related Lung Pathologies

Overview
Date 2006 Apr 13
PMID 16608061
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Our goal is to enhance the ability to differentiate normal lung from subtle pathologies via multidetector row CT (MDCT) by extending a two-dimensional (2-D) texturebased tissue classification [adaptive multiple feature method (AMFM)] to use three-dimensional (3-D) texture features. We performed MDCT on 34 humans and classified volumes of interest (VOIs) in the MDCT images into five categories: EC, emphysema in severe chronic obstructive pulmonary disease (COPD); MC, mild emphysema in mild COPD; NC, normal appearing lung in mild COPD; NN, normal appearing lung in normal nonsmokers; and NS, normal appearing lung in normal smokers. COPD severity was based upon pulmonary function tests (PFTs). Airways and vessels were excluded from VOIs; 24 3-D texture features were calculated; and a Bayesian classifier was used for discrimination. A leave-one-out method was employed for validation. Sensitivity of the four-class classification in the form of 3-D/2-D was: EC: 85%/71%, MC: 90%/82%; NC: 88%/50%; NN: 100%/60%. Sensitivity and specificity for NN using a two-class classification of NN and NS in the form of 3-D/2-D were: 99%/72% and 100%/75%, respectively. We conclude that 3-D AMFM analysis of lung parenchyma improves discrimination compared to 2-D AMFM of the same VOIs. Furthermore, our results suggest that the 3-D AMFM may provide a means of discriminating subtle differences between smokers and nonsmokers both with normal PFTs.

Citing Articles

Association of Ground-Glass Opacities with Systemic Inflammation and Progression of Emphysema.

Fortis S, Guo J, Nagpal P, Chaudhary M, Newell Jr J, Gerard S Am J Respir Crit Care Med. 2024; 210(12):1432-1440.

PMID: 38843116 PMC: 11716031. DOI: 10.1164/rccm.202310-1825OC.


Repeatability of Pulmonary Quantitative Computed Tomography Measurements in Chronic Obstructive Pulmonary Disease.

Motahari A, Barr R, Han M, Anderson W, Barjaktarevic I, Bleecker E Am J Respir Crit Care Med. 2023; 208(6):657-665.

PMID: 37490608 PMC: 10515564. DOI: 10.1164/rccm.202209-1698PP.


Imaging-based assessment of lung function in a population cooking indoors with biomass fuel: a pilot study.

Kizhakke Puliyakote A, Stapleton E, Durairaj K, Karuppusamy K, Kathiresan G, Shanmugam K J Appl Physiol (1985). 2023; 134(3):710-721.

PMID: 36759166 PMC: 10027118. DOI: 10.1152/japplphysiol.00286.2022.


Quantitative Imaging Metrics for the Assessment of Pulmonary Pathophysiology: An Official American Thoracic Society and Fleischner Society Joint Workshop Report.

Hsia C, Bates J, Driehuys B, Fain S, Goldin J, Hoffman E Ann Am Thorac Soc. 2023; 20(2):161-195.

PMID: 36723475 PMC: 9989862. DOI: 10.1513/AnnalsATS.202211-915ST.


Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study.

Chaudhary M, Hoffman E, Guo J, Comellas A, Newell Jr J, Nagpal P Lancet Digit Health. 2023; 5(2):e83-e92.

PMID: 36707189 PMC: 9896720. DOI: 10.1016/S2589-7500(22)00232-1.